Steven Sourbron

Steven Sourbron

Auto-generated profile, based on publicly available information

Steven Sourbron

Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2020 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
ABAnneloes de Boer
Anneloes de Boer
GVGiulia Villa
Giulia Villa
OBOctavia Bane
Octavia Bane
MBMichael Bock
Michael Bock
ECEleanor F. Cox
Eleanor F. Cox
ACAnna Caroli
Anna Caroli
Background: Phase‐contrast (PC) MRI is a feasible and valid noninvasive technique to measure renal artery blood flow, showing potential to support diagnosis and monitoring of renal diseases. However, the variability in measured renal blood flow values across studies is large, most likely due to differences in PC‐MRI acquisition and processing. Standardized acquisition and processing protocols are therefore needed to minimize this variability and maximize the potential of renal PC‐MRI as a clinically useful tool.Purpose: To build technical recommendations for the acquisition, processing, and analysis of renal 2D PC‐MRI data in human subjects to promote standardization of renal blood flow measurements and facilitate the comparability of results across scanners and in multicenter clinical studies.Study Type: Systematic consensus process using a modified Delphi method.Population: Not applicable.Sequence Field/Strength: Renal fast gradient echo‐based 2D PC‐MRI.Assessment: An international panel of 27 experts from Europe, the USA, Australia, and Japan with 6 (interquartile range 4–10) years of experience in 2D PC‐MRI formulated consensus statements on renal 2D PC‐MRI in two rounds of surveys. Starting from a recently published systematic review article, literature‐based and data‐driven statements regarding patient preparation, hardware, acquisition protocol, analysis steps, and data reporting were formulated.Statistical Tests: Consensus was defined as ≥75% unanimity in response, and a clear preference was defined as 60–74% agreement among the experts.Results: Among 60 statements, 57 (95%) achieved consensus after the second‐round survey, while the remaining three showed a clear preference. Consensus statements resulted in specific recommendations for subject preparation, 2D renal PC‐MRI data acquisition, processing, and reporting.Data Conclusion: These recommendations might promote a widespread adoption of renal PC‐MRI, and may help foster the set‐up of multicenter studies aimed at defining reference values and building larger and more definitive evidence, and will facilitate clinical translation of PC‐MRI.Level of Evidence: 1Technical Efficacy Stage: 1

26 August 2021 in EJNMMI Physics
Verified
Journal Article
Open access
PDF file
ELEve Lennie
Eve Lennie
CTCharalampos Tsoumpas
Charalampos Tsoumpas
SSSteven Sourbron
Steven Sourbron
Phantoms are commonly used throughout medical imaging and medical physics for a multitude of applications, the designs of which vary between modalities and clinical or research requirements. Within positron emission tomography (PET) and nuclear medicine, phantoms have a well-established role in the validation of imaging protocols so as to reduce the administration of radioisotope to volunteers. Similarly, phantoms are used within magnetic resonance imaging (MRI) to perform quality assurance on clinical scanners, and gel-based phantoms have a longstanding use within the MRI research community as tissue equivalent phantoms. In recent years, combined PET/MRI scanners for simultaneous acquisition have entered both research and clinical use. This review explores the designs and applications of phantom work within the field of simultaneous acquisition PET/MRI as published over the period of a decade. Common themes in the design, manufacture and materials used within phantoms are identified and the solutions they provided to research in PET/MRI are summarised. Finally, the challenges remaining in creating multimodal phantoms for use with simultaneous acquisition PET/MRI are discussed. No phantoms currently exist commercially that have been designed and optimised for simultaneous PET/MRI acquisition. Subsequently, commercially available PET and nuclear medicine phantoms are often utilised, with CT-based attenuation maps substituted for MR-based attenuation maps due to the lack of MR visibility in phantom housing. Tissue equivalent and anthropomorphic phantoms are often developed by research groups in-house and provide customisable alternatives to overcome barriers such as MR-based attenuation correction, or to address specific areas of study such as motion correction. Further work to characterise materials and manufacture methods used in phantom design would facilitate the ability to reproduce phantoms across sites.

30 September 2016 in Acta Radiologica
Verified
Journal Article
Closed access
EEEli Eikefjord
Eli Eikefjord
EAErling Andersen
Erling Andersen
EHErlend Hodneland
Erlend Hodneland
EHErik A Hanson
Erik A Hanson
SSSteven Sourbron
Steven Sourbron
JRJarle T Rørvik
Jarle T Rørvik
Background: High repeatability, accuracy, and precision for renal function measurements need to be achieved to establish renal dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a clinically useful diagnostic tool. Purpose: To investigate the repeatability, accuracy, and precision of DCE-MRI measured renal perfusion and glomerular filtration rate (GFR) using iohexol–GFR as the reference method. Material and Methods: Twenty healthy non-smoking volunteers underwent repeated DCE-MRI and an iohexol–GFR within a period of 10 days. Single-kidney (SK) MRI measurements of perfusion (blood flow, Fb) and filtration (GFR) were derived from parenchymal intensity time curves fitted to a two-compartment filtration model. The repeatability of the SK-MRI measurements was assessed using coefficient of variation (CV). Using iohexol–GFR as reference method, the accuracy of total MR–GFR was determined by mean difference (MD) and precision by limits of agreement (LoA). Results: SK-Fb (MR1, 345 ± 84; MR2, 371 ± 103 mL/100 mL/min) and SK–GFR (MR1, 52 ± 14; MR2, 54 ± 10 mL/min/1.73 m2) measurements achieved a repeatability (CV) in the range of 15–22%. With reference to iohexol–GFR, MR–GFR was determined with a low mean difference but high LoA (MR1, MD 1.5 mL/min/1.73 m2, LoA [−42, 45]; MR2, MD 6.1 mL/min/1.73 m2, LoA [−26, 38]). Eighty percent and 90% of MR–GFR measurements were determined within ± 30% of the iohexol–GFR for MR1 and MR2, respectively. Conclusion: Good repeatability of SK-MRI measurements and good agreement between MR–GFR and iohexol–GFR provide a high clinical potential of DCE-MRI for renal function assessment. A moderate precision in MR-derived estimates indicates that the method cannot yet be used in clinical routine.

13 October 2023 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
BDBen R. Dickie
Ben R. Dickie
ZAZaki Ahmed
Zaki Ahmed
JAJonathan Arvidsson
Jonathan Arvidsson
LBLaura C. Bell
Laura C. Bell
DBDavid L. Buckley
David L. Buckley
OIon behalf of The Perfusion Study Group of the ISMRM
on behalf of The Perfusion Study Group of the ISMRM
This manuscript describes the ISMRM OSIPI (Open Science Initiative for Perfusion Imaging) lexicon for dynamic contrast‐enhanced and dynamic susceptibility‐contrast MRI. The lexicon was developed by Taskforce 4.2 of OSIPI to provide standardized definitions of commonly used quantities, models, and analysis processes with the aim of reducing reporting variability. The taskforce was established in February 2020 and consists of medical physicists, engineers, clinicians, data and computer scientists, and DICOM (Digital Imaging and Communications in Medicine) standard experts. Members of the taskforce collaborated via a slack channel and quarterly virtual meetings. Members participated by defining lexicon items and reporting formats that were reviewed by at least two other members of the taskforce. Version 1.0.0 of the lexicon was subject to open review from the wider perfusion imaging community between January and March 2022, and endorsed by the Perfusion Study Group of the ISMRM in the summer of 2022. The initial scope of the lexicon was set by the taskforce and defined such that it contained a basic set of quantities, processes, and models to enable users to report an end‐to‐end analysis pipeline including kinetic model fitting. We also provide guidance on how to easily incorporate lexicon items and definitions into free‐text descriptions (e.g., in manuscripts and other documentation) and introduce an XML‐based pipeline encoding format to encode analyses using lexicon definitions in standardized and extensible machine‐readable code. The lexicon is designed to be open‐source and extendable, enabling ongoing expansion of its content. We hope that widespread adoption of lexicon terminology and reporting formats described herein will increase reproducibility within the field.

16 August 2021 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
BABashair Alhummiany
Bashair Alhummiany
DSDavid Shelley
David Shelley
MSMargaret Saysell
Margaret Saysell
MOMaria‐Alexandra Olaru
Maria‐Alexandra Olaru
BKBernd Kühn
Bernd Kühn
KSKanishka Sharma
Kanishka Sharma

19 December 2023 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
ESEve S. Shalom
Eve S. Shalom
HKHarrison Kim
Harrison Kim
RHRianne A. van der Heijden
Rianne A. van der Heijden
ZAZaki Ahmed
Zaki Ahmed
RPReyna Patel
Reyna Patel
AKAnahita Fathi Kazerooni
Anahita Fathi Kazerooni
Purpose: has often been proposed as a quantitative imaging biomarker for diagnosis, prognosis, and treatment response assessment for various tumors. None of the many software tools for quantification are standardized. The ISMRM Open Science Initiative for Perfusion Imaging–Dynamic Contrast‐Enhanced (OSIPI‐DCE) challenge was designed to benchmark methods to better help the efforts to standardize measurement.Methods: A framework was created to evaluate values produced by DCE‐MRI analysis pipelines to enable benchmarking. The perfusion MRI community was invited to apply their pipelines for quantification in glioblastoma from clinical and synthetic patients. Submissions were required to include the entrants' values, the applied software, and a standard operating procedure. These were evaluated using the proposed score defined with accuracy, repeatability, and reproducibility components.Results: Across the 10 received submissions, the score ranged from 28% to 78% with a 59% median. The accuracy, repeatability, and reproducibility scores ranged from 0.54 to 0.92, 0.64 to 0.86, and 0.65 to 1.00, respectively (0–1 = lowest–highest). Manual arterial input function selection markedly affected the reproducibility and showed greater variability in analysis than automated methods. Furthermore, provision of a detailed standard operating procedure was critical for higher reproducibility.Conclusions: This study reports results from the OSIPI‐DCE challenge and highlights the high inter‐software variability within estimation, providing a framework for ongoing benchmarking against the scores presented. Through this challenge, the participating teams were ranked based on the performance of their software tools in the particular setting of this challenge. In a real‐world clinical setting, many of these tools may perform differently with different benchmarking methodology.